← Back to Screener
The Beauty Health Company Class A Common Stock (SKIN)
Price$0.88
Favorite Metrics
Price vs S&P 500 (26W)-45.37%
Price vs S&P 500 (4W)-28.72%
Market Capitalization$116.62M
All Metrics
P/CF (Annual)3.11x
Book Value / Share (Quarterly)$0.48
P/TBV (Annual)7.01x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-6.32%
Cash Flow / Share (Quarterly)$0.25
Price vs S&P 500 (YTD)-38.48%
Gross Margin (TTM)67.68%
Net Profit Margin (TTM)-3.16%
EPS (TTM)$-0.09
10-Day Avg Trading Volume0.56M
EPS Excl Extra (TTM)$-0.09
Revenue Growth (5Y)20.36%
EPS (Annual)$-0.08
ROI (Annual)-2.24%
Gross Margin (Annual)67.68%
Net Profit Margin (5Y Avg)-33.82%
Cash / Share (Quarterly)$1.82
Revenue Growth QoQ (YoY)-1.35%
ROA (Last FY)-1.90%
Revenue Growth TTM (YoY)-10.02%
EBITD / Share (TTM)$0.02
ROE (5Y Avg)-67.57%
Operating Margin (TTM)-0.90%
Cash Flow / Share (Annual)$0.25
P/B Ratio1.91x
P/B Ratio (Quarterly)2.90x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)0.83x
Net Interest Coverage (TTM)-0.30x
ROA (TTM)-1.74%
EV / EBITDA (TTM)100.83x
EPS Incl Extra (Annual)$-0.08
Current Ratio (Annual)1.66x
Quick Ratio (Quarterly)1.37x
3-Month Avg Trading Volume0.62M
52-Week Price Return6.14%
EV / Free Cash Flow (Annual)7.68x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.20
P/S Ratio (Annual)0.39x
Asset Turnover (Annual)0.60x
52-Week High$2.69
Operating Margin (5Y Avg)-12.96%
EPS Excl Extra (Annual)$-0.08
CapEx CAGR (5Y)6.21%
26-Week Price Return-36.62%
Quick Ratio (Annual)1.37x
13-Week Price Return-40.73%
Total Debt / Equity (Annual)5.97x
Current Ratio (Quarterly)1.66x
Enterprise Value$248.336
Revenue / Share Growth (5Y)-7.28%
Asset Turnover (TTM)0.55x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.66x
Pretax Margin (Annual)-1.97%
Cash / Share (Annual)$1.82
3-Month Return Std Dev80.79%
Gross Margin (5Y Avg)63.48%
Net Income / Employee (TTM)$-0
ROE (Last FY)-15.59%
Net Interest Coverage (Annual)-0.48x
EPS Basic Excl Extra (Annual)$-0.08
P/FCF (TTM)3.61x
Receivables Turnover (TTM)12.18x
EV / Free Cash Flow (TTM)7.68x
Total Debt / Equity (Quarterly)5.97x
EPS Incl Extra (TTM)$-0.09
Receivables Turnover (Annual)12.18x
ROI (TTM)-2.01%
P/S Ratio (TTM)0.39x
Pretax Margin (5Y Avg)-33.84%
Revenue / Share (Annual)$2.38
Tangible BV / Share (Annual)$0.20
Price vs S&P 500 (52W)-28.95%
Year-to-Date Return-34.34%
5-Day Price Return-2.90%
EPS Normalized (Annual)$-0.08
ROA (5Y Avg)-8.65%
Net Profit Margin (Annual)-3.16%
Month-to-Date Return2.55%
Cash Flow / Share (TTM)$-0.40
EBITD / Share (Annual)$0.02
Operating Margin (Annual)-0.90%
LT Debt / Equity (Annual)3.94x
P/CF (TTM)3.11x
ROI (5Y Avg)-10.20%
LT Debt / Equity (Quarterly)3.94x
EPS Basic Excl Extra (TTM)$-0.09
P/TBV (Quarterly)7.01x
P/B Ratio (Annual)2.90x
Inventory Turnover (TTM)1.66x
Pretax Margin (TTM)-1.97%
Book Value / Share (Annual)$0.48
Price vs S&P 500 (13W)-43.60%
Beta1.19x
P/FCF (Annual)3.61x
Revenue / Share (TTM)$2.36
ROE (TTM)-15.43%
52-Week Low$0.76
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
2.57
2.57
2.57
2.57
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
SKINThe Beauty Health Company Class A Common Stock | 0.39x | 20.36% | 67.68% | -0.90% | $0.88 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
The Beauty Health Company designs and manufactures aesthetic technology platforms for professional beauty treatments. Its brand portfolio includes Hydrafacial for skin resurfacing, SkinStylus for microneedling, and Keravive for scalp care, with revenue generated through device sales and recurring consumables.